Japan's Transgenic And National Medical Center Collaborate On New Flu Diagnosis
This article was originally published in PharmAsia News
Executive Summary
Tokyo-based International Medical Center of Japan and biotech firm Transgenic will jointly research and develop new antibodies for flu virus diagnosis. The center will use gene-engineered mice provided by Transgenic to develop an H1N1 antibody. The antibody will help to quickly diagnose the flu in patients. The two aim to commercialize the technology inside medical facilities this winter. (Click here for more - Japanese language